Following authorisation from a liberty and custody judge, the Investigation Services of the Autorité de la concurrence carried out unannounced inspections on 14 March, at the premises of companies suspected of having implemented anticompetitive practices in the medical biology sector.



Such inspections do not prejudge the guilt of the companies concerned by the alleged practices, which can only be established following an investigation on the merits.



The Autorité de la concurrence will not comment further, either on the companies or on the practices in question.
      
      
      

                
        
      
            Compliance
      
      
            Information for undertakings
      
      
            

For the purposes of informing undertakings not concerned by the unannounced inspections and thereby ensuring equal access to the leniency programme for these undertakings, the Autorité publishes a press release at the end of the unannounced inspections, except in special circumstances. This press release does not mention the identity of the undertakings visited, and is without prejudice to the presumption of innocence.



Do you have concerns about past or current practices? Act promptly and apply for our leniency programme, which enables you to report information to the Autorité de la concurrence that may help to establish the existence of anticompetitive practices.For an initial informal and confidential discussion, please contact Anne Krenzer, our Leniency Officer, at +33 1 55 04 00 46 or by e-mail.
      
    
      

                
          
  
    Contact(s)
          
                
          
              
          
        
              


      
      
      
  
    
      
            Nicola Crawford
      
      
            Communication officer
      
    
    
      
            +33155040151
      
      
     Contact us by e-mail

Unannounced Inspections in Medical Biology Sector by Autorité de la concurrence

The Autorité de la concurrence, with authorization from a judge, conducted surprise inspections at companies in the medical biology sector for alleged anticompetitive practices. The inspections do not imply guilt, and the Autorité will not disclose further details. Undertakings not involved in the inspections are encouraged to apply for the leniency program to report any relevant information. The Autorité will release a press statement after the inspections to ensure equal access to leniency, without revealing the companies visited.

Unannounced Inspections in Medical Biology Sector by Autorité de la concurrence

The Autorité de la concurrence conducted unannounced inspections in the medical biology sector to investigate suspected anticompetitive practices.